Identifying high-risk groups for recurrence in endometrial cancer: The role of ESMO–ESGO–ESTRO risk classification

Key Points

• The central aim is to identify high-risk groups for recurrence in endometrial cancer using risk classification methods.
• Utilized ECOG performance status as a clinical parameter.
• Integrated this parameter with ESMO-ESGO-ESTRO risk classification.
• Focused on patients where molecular classification is not available.
• Identified high-risk patients for closer follow-up based on risk classification.
• Validated the reliability of the 2016 risk stratification for therapeutic planning.